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Cell cycleribonucleoproteins A1, A2/B1 and A3 (hnRNPs A/B) are involved in many nuclear
functions that are conﬁned to distinct regions within the nucleus. To characterise and compare the
distribution of the hnRNPs A/B in these subnuclear compartments, their colocalisation with spliceosomal
components, nascent transcripts and other nuclear markers in HeLa cells was investigated by
immunostaining and transfection of GFP constructs. The mechanisms of this localisation were further
explored by treating cells with detergent, nucleases and transcription inhibitors. We have also examined the
dynamics of A2/B1 throughout the cell cycle. Our results show that hnRNPs A/B have different subnuclear
localisations, with A1 differentially localised to the nuclear envelope, and A2/B1 and A3 enriched around
nucleoli. This pattern of distribution was dependent on RNA integrity and active transcription. The hnRNPs A/
B preferentially colocalised with a subset of splicing factors. Signiﬁcantly, only rarely did transcription
factories colocalise with high levels of these hnRNPs. Moreover, localisation of A2/B1 changed with cell cycle
stage. Our ﬁndings show that the subnuclear localisation of the hnRNPs A/B is differentially, spatially and
temporally regulated, and suggest that this localisation may be relevant to their nuclear functions.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionThe heterogeneous nuclear ribonucleoprotein (hnRNP) A/B family
of proteins is comprised of A1, A2/B1, A3 and A0. These multi-
functional proteins have a wide range of roles in diverse cellular
events, including RNA processing and trafﬁcking [1], cell senescence
[2], translational regulation [3], cell cycle regulation [4], stress res-
ponse [5] and miRNA processing [6]. Within the nucleus, aside from
their well-recognised role in packaging nascent RNA, the hnRNPs A/B
may also be involved in splice site selection [7,8], transcription
regulation [9], telomere maintenance [10–13], DNA replication [14]
and splicing regulation [15–19].
While much information is available about the activity of the
hnRNPs A/B in the nucleus, in particular for A1 and A2/B1, less is
known about the localisation of these proteins in subnuclear
compartments. A1 and A2/B1 have been found in nucleolar prepara-
tions, along with other splicing factors such as U2AF [20]. However, as
it is possible that subcellular fractionation procedures may disrupt
normal cellular organisation and produce artifacts, localisation
validation by a variety of methods is necessary for conﬁrmation of
these ﬁndings [21]. Several studies [22,23] employing ﬂuorescentonuclear proteins; RRM, RNA
oteins
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l rights reserved.immunostaining methods have shown that the hnRNPs A/B display
widespread nucleoplasmic staining that is excluded from nucleoli, but
due to the overwhelming abundance of these proteins in the nucleus
further details were not discernable. While the hnRNPs A/B have
consistently been isolated in most, but not all, stages of spliceosomal
assembly [24–29], these studies have been conducted in vitro and
require further investigation for their ﬁndings to be extended to the
situation in vivo.
Most nuclear processes, including RNA processing, transcription
and DNA replication, are organised spatially and temporally [30].
Three of the most prominent subnuclear structures are nucleoli, Cajal
bodies and splicing speckles or splicing factor compartments, which
have different structural and functional properties [31]. For example,
newly assembled small nuclear ribonucleoproteins (snRNPs) are
imported from the cytoplasm into the nucleus where they ﬁrst
localise transiently in Cajal bodies and undergo modiﬁcation. The
snRNPs then accumulate in splicing factor compartments before
recruitment to active sites of transcription [32–34]. In addition, DNA
replication and transcription occur at deﬁned nuclear sites known as
replication factories and transcription factories [35,36]. Thus, in this
highly dynamic and intricately compartmentalised environment,
detailed in vivo characterisation of subnuclear localisation is essential
to advance our understanding of the function of nuclear proteins such
as the hnRNPs A/B.
In the present study, we have investigated the colocalisation of
hnRNPs A1, A2/B1 and A3 with spliceosomal and other nuclear com-
ponents in ﬁxed and living cells. We show that although they are
Fig. 1. Subnuclear localisation of A2/B1 in (A) HeLa cells, (B) Colo16 cells, (C) primary
keratinocytes and (D) hippocampal progenitor cells. Fixed cells were immunostained
using a rabbit polyclonal antibody against A2/B1, followed by an anti-rabbit Alexaﬂuor-
488-conjugated secondary antibody, and imaged using confocal microscopy. Arrows
point to enriched regions of A2/B1 surrounding the nucleoli. Bar, 10 μm.
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markedly different from that of A2 and A3. A1 preferentially localises
at the nuclear envelope, whereas A2 and A3 concentrate in the
perinucleolar region. These features were highlighted by detergent-
mediated removal of the diffuse nucleoplasmic proteins. Treatment
with RNase A or transcription inhibitors perturbed this localisation,
demonstrating its dependence on interactions with RNA. Some
spliceosomal components (U2AF65, snRNAs and Sm proteins) spatially
overlapped with A2/B1 whereas others (SC-35) did not, suggesting
that the hnRNPs A/B may associate preferentially with a subset of the
spliceosomal complexes. High levels of hnRNPs A/B were associated
only infrequently with nascent transcripts, suggesting a temporal
separation between pre-mRNA synthesis and its association with
these proteins. Finally, cell cycle studies revealed that the perinucleo-
lar concentration of A2/B1 seen in interphase was disrupted in early
mitosis.
2. Materials and methods
2.1. Cell culture
HeLa cells were maintained in DMEM (Gibco, Victoria, Australia)
containing 10% newborn calf serum, 100 U/ml penicillin, 100 μg/mlFig. 2. The perinucleolar localisation of A2/B1 was veriﬁed using several methods.
(A) HeLa cell ﬁxed 16 h after transfection with A2-GFP plasmid DNA. (B) Live B104 cell
imaged 4 h after microinjection with A2-GFP plasmid DNA. (C) HeLa cell that was
detergent extracted with 0.2% Triton X-100/CSK buffer for 5 min prior to ﬁxation, then
ﬁxed and immunostained for A2/B1 followed by Alexaﬂuor-488-conjugated secondary
antibody. Arrows point to enriched regions of A2/B1 surrounding the nucleoli. Bar,
10 μm.streptomycin, HEPES, pH 7.4 at 37 °C in a humidiﬁed 5% CO2
atmosphere.
2.2. Antibodies
Rabbit polyclonal antibodies directed against A1 (1:40), A2/B1 (1:200)
and the N-terminal of A3 (1:500) were raised in our laboratory [37]. The
speciﬁcity of these antibodies was conﬁrmed by peptide blocking
experiments. The following mouse monoclonal antibodies were also
used in this study: anti-hnRNP A1, Clone 4B10 (Sigma, Sydney, Australia;
1:1000), anti-SC-35 (Sigma, 1:2000), anti-Sm (Y12) (AbCam, Cambridge,
UK; 1:100), anti-2,2,7-trimethylguanosine (anti-TMG) (Calbiochem,Fig. 3. Differential subnuclear distribution of hnRNPs A/B. HeLa cells in interphase,
metaphase and anaphase were ﬁxed and double-labelled with a mouse monoclonal
antibody against A1 followed by anti-mouse Alexaﬂuor-546-conjugated secondary
antibody, (middle column, red in overlay) and rabbit polyclonal antibodies against A2/
B1 or A3 followed by anti-rabbit Alexaﬂuor-488-conjugated secondary antibody (left
column, green in overlay). Cells were then imaged using confocal microscopy. Arrows
point to the regions enriched for A1 only, while arrowheads point to the regions
enriched for A2/B1 or A3 only. Bar, 10 μm.
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1:3000) and anti-bromodeoxyuridine (anti-BrdU) (Chemicon, Sydney,
Australia; 1:50). The following secondary antibodies were all from
Molecular Probes (Victoria, Australia): Alexa 488 goat anti-mouse
(1:1000), Alexa 546 goat anti-mouse (1:3000), Alexa 488 goat anti-rabbit
(1:1000) and Alexa 546 goat anti-mouse (1:3000).
2.3. Immunocytochemistry
HeLa cells were grown on 12 mm glass coverslips to ∼60%
conﬂuency, after which cells were ﬁxed in 4% paraformaldehyde
(PFA)/phosphate-buffered saline (PBS) for 10 min and permeabilised
with 0.1% Triton X-100/PBS for 10 min, both at room temperature. In
some cases, detergent extraction was performed on live cells prior to
immunostaining. As well, a range of concentrations of Triton X-100
(0.05–10%) in PHEM buffer (60 mM PIPES, 25 mM HEPES, 20 mM
EGTA, 1 mM MgCl2, pH 7.4 with KOH) was tested on GFP-transfected
HeLa cells, and the optimal concentration (0.2%) was used for
subsequent experiments. Following permeabilisation or detergent
extraction, cells were immunostained using the appropriate primary
and secondary antibodies. Images were then acquired on a laser-
scanning confocal microscope (LSM 510 Meta, Zeiss Inc., Oberkochen,
Germany). Other cell types were processed in the same manner.
2.4. Transient transfection assays
GFP-tagged constructs of nuclear markers B23, H2B, coilin, and
SMN were propagated in DH5α cells. To generate A2-GFP, PCR was
performedonmouse skin cDNAusing a forwardprimer to introduce an
XhoI site and Kozac sequence, and a reverse primer to introduce an
AgeI site ﬂanking the hnRNP A2 sequence. The ampliﬁed product was
gel-extracted, ligated into pGemT-Easy Vector and electroporated into
DH5α cells. Positive clones were digested with XhoI and AgeI, and the
insert was subcloned into pEGFP-N1 (Clontech, CA). The resulting
plasmid was propagated in Stbl2 cells (Invitrogen, Victoria, Australia).
HeLa cells grown in 24-well plates were transfected with 200 ng of
plasmid DNA per well using Fugene 6 (Roche, Sydney, Australia), and
ﬁxed 16 h post-transfection. B104 cells were imaged 4 h after
microinjection of 100 ng of A2-GFP plasmid DNA.
2.5. Nuclease digestion of living cells
Nuclease digestion was performed as previously described [38].
HeLa cells grown overnight on coverslips were extracted in 0.2% Triton
X-100 in CSK buffer (100 mM NaCl, 300 mM sucrose, 10 mM PIPES at
pH 7.4, 3 mM MgCl2, 1 mM EGTA, 1 mM PMSF) for 5 min at room
temperature. The cells were treated with either 100 μg/ml RNase A
(Fermentas, Ontario, Canada) in CSK buffer for 10 min at 37 °C, or
100 μg/ml DNase 1 (Worthington, NJ) in PBS with 5 mM MgCl2 for
20 min at room temperature. Then, cells were ﬁxed and processed as
for immunostaining. In addition, cells were stained with Hoechst
32258 Dye (Molecular Probes, 1:10,000) in PBS for 5 min to monitor
DNA levels, and some coverslips were also incubated for 5 s in Pyronin
Y Dye (Sigma, 1:15,000) to monitor RNA levels.Fig. 4. Comparison of A2/B1 subnuclear distribution with nuclear markers. (A) HeLa
cells were double-labelled with mouse monoclonal antibodies against splicing factors
followed by anti-mouse Alexaﬂuor-546-conjugated secondary antibody, (left column,
red in overlay) and rabbit polyclonal antibody against A2/B1 followed by anti-rabbit
Alexaﬂuor-488-conjugated secondary antibody (middle column, green in overlay). (B)
HeLa cells were transfected with GFP-tagged markers (left column, green in overlay) for
various subnuclear compartments and immunostained for A2/B1 followed by
Alexaﬂuor-546-conjugated secondary antibody (middle column, red in overlay). Cells
were then imaged using confocal microscopy. Arrows point to the regions of
colocalisation, while arrowheads point to the regions enriched for either the red or
green signal only. Bar, 10 μm.2.6. Transcription inhibition
HeLa cells were grown overnight on coverslips and treated the
following day with 5 μg/ml actinomycin D (Sigma) for 1–3 h or 50 μg/
ml α-amanitin (Sigma) for 5 h, both at 37 °C.
Fig. 5. Interaction of A2/B1 with nucleic acids. (A) HeLa cells were immunostained for
A2/B1 followed by Alexaﬂuor-488-conjugated secondary antibody (middle column,
green in overlay), and then stained for DNA using Hoechst Dye (left, blue in overlay) or
RNA using Pyronin Y Dye (left, red in overlay). The arrow points to a region of
colocalisation, while the arrowhead points to a region enriched for the red signal only.
(B) HeLa cells were extracted with 0.2% Triton X-100/CSK buffer for 5 min, followed by
treatment with 100 μg/ml RNase A or 100 μg/ml DNase 1. Cells were then ﬁxed and
stained for RNA and DNA using Pyronin Y Dye and Hoechst Dye, respectively. The
concentrations of RNase and DNase used almost completely removed RNA and DNA,
respectively. (C) HeLa cells were treated using the same conditions as in (B). Control
cells were extracted with detergent, but without nuclease treatment. Cells were then
ﬁxed and immunostained for A2/B1 followed by Alexaﬂuor-488-conjugated secondary
antibody (middle column, green in overlay) and U2AF65 followed by Alexaﬂuor-546-
conjugated secondary antibody (left column, red in overlay). Images were taken using
confocal microscopy at constant settings. The brightness and contrast of the overlaid
image for the RNase A-treated cells have been adjusted to visualise the signals for A2/B1
and U2AF65. Bar, 10 μm.
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as described earlier. Images were collected using confocal microscopy
with the same microscope settings used for every time point tested.
2.7. BrUTP labelling
For BrUTP labelling, a variation of the method presented in Andersen
et al. [39] was used. HeLa cells were grown overnight on coverslips,
permeabilised, and preincubated in physiological buffer (PB) (100 mM
KOAc, 30 mM KCl, 10 mM Na2HPO4, 1 mM MgCl2, 1 mM Na2ATP, 1 mM
DTT, 0.2 mM PMSF and 80 U/ml RNAsin) at 33 °C for 2 min. They were
then incubated in transcriptionmix (1mMATP, 0.1mMGTP, 0.1mMCTP,
0.1 mM BrUTP, 1 mM MgCl2 in PB) at 33 °C for 15 min. Cells were then
washed, permeabilisedon ice,ﬁxedand immunostained forBrdUandthe
hnRNPsA/B, afterwhich theywere imagedusing confocalmicroscopy. To
conﬁrm that our results were not method-dependent, cells were also
labelled with BrUTP by another method [40]. For this method a range of
conditions including duration of labelling and detergent concentrations,
was used. Both methods gave comparable results.
2.8. Cell cycle synchronisation
HeLa cells were synchronised using the mitotic shake-off method
[41]. Mitotic cells were obtained by vigorously shaking an asynchro-
nously growing cell population for 1 min in 5 ml of medium. These
cells were then plated onto ﬁbronectin-coated coverslips (5 μg/50 μl)
at a density of ∼1.6×105 and ∼9.0×103 cells/well for ﬂow cytometry
(FACS) and immunostaining, respectively. At 2 h intervals, cells for
FACS were harvested by trypsinisation, ﬁxed in 70% ethanol and the
DNA stained with propidium iodide (25 μg/ml) containing RNase A
(100 μg/ml). At the same time points, cells for immunoﬂuorescence
microscopy were ﬁxed in 4% PFA/PBS, immunostained and the DNA
stained using Hoechst 32258 Dye. Cell synchrony of the mitotic
population was monitored by FACS analysis of the propidium iodide-
stained cells. Cells for immunoﬂuorescence studies were assigned cell
cycle stage based on the DNA content of the cells collected at each time
point. The data obtained from FACS analysis were gated to exclude
small cellular debris and clumps or multiples of cells.
3. Results
3.1. Different hnRNPs A/B are localised in overlapping but distinct regions
within the nucleoplasm
In HeLa cells, A2/B1 displayed widespread nucleoplasmic immu-
nostaining that was enriched around nucleoli but excluded from them
(Fig. 1A, short arrows), in accord with previous studies [22]. Similar
staining features were evident in other cell types, including Colo16 (a
keratinocyte cell line) [42], primary proliferating human keratinocytes
and hippocampal progenitor cells (Fig. 1B–D). Thus, this pattern of
localisationwas not cell-type dependent since it was present in simple
epithelial (HeLa), stratiﬁed epidermal (Colo16 and primary keratino-
cytes) and neuronal (hippocampal) cells.
Similar localisationpatternswere obtained usingother experimental
approaches. Transfection and microinjection of A2-GFP constructs into
HeLa cells and B104 neuroblastoma cells, respectively, produced a
ﬂuorescence pattern similar to that of immunostaining of endogenous
proteins, with enrichment of signal around nucleoli (Fig. 2A,B). This
pattern was evident in both ﬁxed (Fig. 2A) and living cells (Fig. 2B). In
addition, detergent extraction was performed prior to ﬁxation of living
cells, in order to remove soluble proteins. The enrichment of A2/B1
around nucleoli persisted under these conditions (Fig. 2C), demonstrat-
ing that these local concentrations aremaintained by stable interactions
with detergent-resistant components. Indeed, a large pool of hnRNPs
was still present in the cells after extraction with the highest con-
centration of detergent tested (10%) (data not shown).Differences between the immunostaining patterns of A1, A2/B1 and
A3 were observed. The A1 signal was concentrated at the nuclear
envelope of most cells (Fig. 3, arrows), and diminished in the centre of
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nucleoplasm (Fig. 3, arrowheads). Thus, a distinctive “border”was pro-
duced when the A1 signal was overlaid on that of A2/B1 or A3 (Fig. 3,
overlays). Interestingly, this patternwasmaintained in cells undergoing
metaphase and anaphase. This may represent a redistribution of A1 into
the endoplasmic reticulum network, which remains intact as the
nuclear envelope disassembles during mitosis [43].
3.2. Colocalisation of hnRNP A2/B1 with spliceosomal and other nuclear
proteins
To further characterise the distribution of A2/B1, we investigated its
colocalisationwith established splicing factors and subnuclear compart-
ments. Detergent extraction was performed on living cells prior to
ﬁxation and immunostaining. As noted above, this procedure reduced
the high nuclear abundance of putatively mobile A2/B1 which normally
occludes ﬁne structural details, thus permitting a more accurate assess-
ment of the extent of colocalisation between different proteins. In
regions surrounding the nucleoli, the signal for A2/B1 overlapped with
proteins recognised by the Y12 antibody and anti-5′-capped trimethyl-
guanosine (TMG) (Fig. 4A top rows, arrows). Y12 is an autoantibody,
derived from mice with a lupus-erythematosus-like syndrome, that
recognises Sm proteins [44], while anti-TMG recognises processed
snRNAs. Overlapping signals were also observed for U2AF65, which is an
early splicing factor (Fig. 4A third row, arrow). Notably, for all three
antibodies, there were enriched foci in the nucleoplasm that did not
colocalise with A2/B1 (Fig. 4A, arrowheads). Similarly, there was noFig. 6. Effect of transcription inhibition on A2/B1 localisation. (A) HeLa cells were treated with
for A2/B1 followed by Alexaﬂuor-488-conjugated secondary antibody (left column, green in
for RNA using Pyronin Y Dye (second column, red in overlay). Images were taken using con
Arrow points to the region around the nucleolar remnants where A2/B1 localisation persistoverlap of signal with splicing factor SC-35 (Fig. 4A bottom row, arrow-
heads),which suggests that A2/B1does not associatewith splicing factor
compartments [45].
To investigate the distribution of A2/B1 with respect to other
subnuclear domains, cells were transfected with DNA expressing GFP-
tagged nuclear markers, and immunostained for A2/B1. The signal for
A2/B1 did not overlap with that of GFP-B23, which is a marker for the
nucleolus [46]. Similarly, there were no concentrations of A2/B1
corresponding to the locations of Cajal bodies and GEMs, as indicated
by GFP-coilin [47] and GFP-SMN [48], respectively (Fig. 4B, arrow-
heads). In contrast, the signal for A2/B1 partially coincidedwith that of
histone 2B-GFP [49] (Fig. 4B, arrows), implying that there was
colocalisation with chromatin.
As A2/B1 was found to colocalise with Sm proteins (recognised by
Y12), snRNAs (recognised by anti-TMG) and U2AF65, co-immunopre-
cipitation experiments were performed to verify the speciﬁcity of the
antibodies used, and to demonstrate that the observed colocalisations
were not due to cross-reactivity between the various antibodies
(Supplementary data).
3.3. hnRNPs A/B associate with nucleic acids
Next, we explored the possibility that A2/B1 localisation may be
dependent on its interactionwith nucleic acids. HeLa cellswere stained
for nucleic acids and immunostained for A2/B1 to determine the extent
of their colocalisation (Fig. 5A). Like histone 2B-GFP, DNA colocalised
with A2/B1, particularly in the perinucleolar region (Fig. 5A, arrow). As5 μg/ml actinomycin D (Act. D) for 1 h or 3 h. Cells were then ﬁxed and immunostained
overlay), stained for DNA using Hoechst Dye (third column, blue in overlay), and stained
focal microscopy at constant settings. (B) Nucleolar remnants at higher magniﬁcation.
ed. Bar, 10 μm in (A), 5 μm in (B).
Fig. 7. hnRNPs A/B do not colocalise stronglywith transcription sites. (A) HeLa cells were
incubated with BrUTP to label nascent transcripts. Labelled cells were immunostained
with anti-BrdU followed by anti-mouse Alexaﬂuor-546-conjugated secondary antibody
(red), and rabbit polyclonal antibodies against A1, A2/B1, A3 (A–C, respectively),
followed by anti-rabbit Alexaﬂuor-488-conjugated secondary antibody (green) and
imaged by confocal microscopy. Localisation of A1 to the nuclear envelope appeared to
have been perturbed by the permeabilization step in the BrUTP labelling procedure.
Distinctive BrUTP-labelled foci are visible (red, short arrows). Image (D) shows, at
higher magniﬁcation, a transcription factory (long arrow) that lacks overlap with A1. (E)
Cells incubated with UTP in place of BrUTP were used as a negative control. (F) As a
positive control, BrUTP-labelled cells were immunostained with anti-BrdU, visualised
using anti-mouse Alexaﬂuor-488-conjugated secondary antibody (green) and stained
for RNA using Pyronin Y Dye (red). Images (G–I) were also obtained at higher
magniﬁcation with immunodetection of hnRNP A1 (G) or A2/B1 (H and I). The adjacent
proﬁles were obtained by scanning along the paths marked by dotted lines on the
images. Bar, 2 μm in (D), and (G–I); 10 μm in (F) with the same magniﬁcation in (A–C,
and E).
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nucleolus, as marked by intense staining of rRNA (Fig. 5A, arrowhead).
There was also a diffuse and homogenous staining of RNA throughout
the nucleoplasm outside the nucleolus.
We then looked at the effect of nuclease treatment on the loca-
lisation of A2/B1, and also U2AF65, an established RNA-binding
protein. Fig. 5B demonstrates the extent of nucleic acid degradation
under the conditions used in the experiments. In control cells that
were not treated with nucleases, staining for DNA was present
throughout the nucleoplasm, and concentrated around the nucleoli.
RNase A treatment completely removed RNA, while most of the DNA
was removed after DNase 1 treatment and there was no discernable
organisation of the DNA remnants.
HeLa cells were treated with nucleases as above and immunostained
forA2/B1andU2AF65.Untreated cells displayed the samestaining features
as described earlier (Fig. 5C, top row). Treatment with RNase A removed
most of the signal for both A2/B1 and U2AF65, and enhancement of the
remaining faint signals revealed that therewasstill considerableoverlap in
signal for the twoproteins (Fig. 5C,middle row). This signal represents the
pool of A2/B1 and U2AF65 that was bound to DNA and/or protein. In
comparison, DNase 1 treatment removed a much smaller proportion of
A2/B1 and U2AF65, preserving a signiﬁcant pool that was bound to RNA
and/or protein (Fig. 5C, bottom row). Thus, although A2/B1 had shown a
greater degree of colocalisation with DNA than with RNA in the earlier
staining experiment (Fig. 5A), its localisationwas more dependent on the
integrity of RNA than DNA. Interestingly, the enrichment of signal around
the nucleoli after DNase treatment was retained by U2AF65 to a greater
extent than that for A2/B1 (Fig. 5C, bottom row). Thus, while the
subnuclear localisation of both A2/B1 and U2AF65 is mostly dependent on
associationwith RNA, there may be differences between the two proteins
with respect to the nature of these associations.
The effect of RNase and DNase treatment on A1 and A3 stain-
ing was the same as that for A2/B1 (data not shown), which implies
that the localisation of all three paralogues is highly dependent
on RNA–protein interactions. These observations were consistent
over at least 3 sets of experiments for each paralogue (data not
shown).
3.4. Localisation of hnRNPs A/B is dependent on transcription activity
As A2/B1 localisation appeared to be RNA-dependent, we investi-
gated whether altering transcription rates would affect the distribu-
tion of these proteins. After 1 h treatment with actinomycin D (which
blocks the activity of RNA polymerases I, II and III), A2/B1 staining
became more evenly distributed throughout the nucleoplasm while
RNA levels and nucleolar size were reduced (Fig. 6A, middle row).
These changes became more pronounced after actinomycin D treat-
ment for 3 h (Fig. 6A, bottom row), but interestingly, a persistent pool
of A2/B1 remained around the nucleolar remnants even when RNA
levels were barely detectable (Fig. 6B, arrows). The same results were
obtained for cells treated with α-amanitin, which selectively blocks
RNA polymerase II (data not shown). Untreated cells showed the same
staining features as described in earlier sections (Fig. 6A, top row).
Similarly, the localisation of A1 and A3 was disrupted by transcription
inhibition with actinomycin D (data not shown), which demonstrates
that the localisation of all the hnRNPs A/B is dependent on ongoing
RNA synthesis.
3.5. The hnRNPs A/B do not preferentially colocalise with transcription
sites
Since we found that the localisation of hnRNPs A/B was closely
associated with transcriptional activity, and as these proteins have
well-established roles in the packaging of nascent mRNA [1], BrUTP
(Fig. 7A–C, red) was used to label nascent transcripts in living cells in
order to determine the extent of their colocalisation with the hnRNPsA/B (green). We found that the majority of transcription factories did
not colocalise with the hnRNP foci. Under higher magniﬁcation, indi-
vidual transcription factories [35] devoid of signal for the hnRNPs,
were clearly discernable (Fig. 7D). As a negative control, cells incubated
Fig. 8. Localisation of A2/B1 changes with cell cycle stages. (A) Cell synchrony of mitotic shake-off cells determined by FACS analysis. (B) HeLa cells at different stages of the cell cycle
were ﬁxed and immunostained for A2/B1 followed by anti-rabbit Alexaﬂuor-488-conjugated secondary antibody (green) and stained for DNA with Hoechst Dye (blue). Bar, 10 μm.
(C) Cells at various stages of the cell cycle (I, interphase; P, prophase; M, metaphase and A, anaphase) were immunostained for A2/B1 (green) as above, and also for SC-35 followed by
anti-mouse Alexaﬂuor-546-conjugated secondary antibody (red). Arrows point to the regions enriched for A2/B1. Bar, 10 μm.
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have any red signal for labelled nascent transcripts (Fig. 7E). As a
positive control, cells labelled with BrUTP (green) and stained for RNA
(red) displayed a uniform colocalisation of both signals in the
nucleoplasm (Fig. 7F). There was also a small subset of transcription
factories that colocated with the hnRNPs (Fig. 7G–I), but it is not
possible to determine if this results from bona ﬁde colocalisation.
3.6. Localisation of A2/B1 changes with cell cycle stage
We had noted that the pattern of localisation of A2/B1 varied bet-
ween cells at different stages of the cell cycle (Fig. 3). In combination
with the observation that transcription rates affect the localisation of
these proteins, we further explored their distribution in synchronised
cells. The cells collected bymitotic shake-off progressed through the cell
cycle entering synthesis (S) and mitosis (M) phases 12 and 17.5 h,
respectively, after plating out, as determined by FACS analysis (Fig. 8A).These results are in agreement with mitotic shake-off cell cycle cha-
racteristics forHeLa cells [50]. Cell cycle stageswere then assigned to the
immunoﬂuorescent data time points. The perinucleolar enrichment of
A2/B1wasmaintained throughout interphase (Fig. 8B (G1-S)) andbegan
dispersing in early mitosis (Fig. 8B (G2/M)). During mitosis, the pattern
of A2/B1 staining was generally diffuse, although there appeared to
be some regional concentrations of staining (Fig. 8B (bottom row), C,
arrows). By comparison, the distribution of SC-35 was more homo-
geneous than the A2/B1 distribution at metaphase (Fig. 8C).
4. Discussion
Sequence comparisons suggest that hnRNPs A1, A2/B1 and A3 are
derived from a common ancestral gene sequence [51]. These proteins
are highly conserved across a variety of eukaryotic species and share
overlapping functions in a number of cellular pathways. Simultaneous
suppression of multiple paralogues resulted in a greater retardation of
1979L.R. Friend et al. / Biochimica et Biophysica Acta 1783 (2008) 1972–1980cell proliferation than suppression of individual paralogues, which
indicates that there is functional compensation by the other para-
logues when only one is suppressed [2,4,52]. Mouse hepatitis virus
(MHV) replication still takes place in the CB3 cell line, which does not
express A1, because the other paralogues can ﬁll its role in RNA
synthesis [53]. Both A1 and A2/B1 have well-documented and highly
similar roles in RNA processing [1], in particular splicing [54]. This
apparent functional redundancy may represent a “backup” system to
ensure that these vital cellular processes can take place even if one of
the paralogues is non-functional.
Although the hnRNPs A/B share a high degree of sequence identity
and structural similarity, the subnuclear localisation of A1 differed
markedly and consistently from that of A2/B1 and A3 (Fig. 3). A1 was
preferentially localised at the nuclear envelope, whereas A2/B1 and A3
were widely distributed but concentrated near nucleoli. All three
proteins possess the same overall organisation of two N-terminal RNA
recognition motifs (RRMs) joined by a short linker, followed by a C-
terminal glycine-rich domain (GRD) [55]. The GRD of A3 is more
similar in sequence to that of A2/B1 than A1, whereas the converse is
true for the RRMs [37]. The subnuclear distribution of A3 resembles
that of A2/B1 more closely than that of A1 throughout interphase,
metaphase and anaphase, which may indicate that the interactions
regulating the localisation of these proteins may be largely deter-
mined by the GRD.
The differential localisation of the hnRNPs A/B may have functional
implications.Alhas beendetected throughoutDNA replicationbodies by
electron microscopy, and its presence has been attributed to the colo-
calisation of replication and transcription [56]. Replicating chromatin
distributes to the nuclear periphery and is largely absent from the
internal nucleoplasmic volume at the later stages of S phase [57]. Thus,
the immunostaining pattern of A1 could reﬂect its associationwith late
replicating DNA. Hence, the differences in the distribution of A1 versus
A2 and A3 may result from their involvement in distinct sets of nuclear
processes.
In addition, our results indicate that localisation of the hnRNPs A/B
is highly dependent on interactions with RNA (Fig. 5). Although
colocalisation of transcription factories (which contain the majority
of nascent extranucleolar transcripts [58]) with hnRNP A/B foci was
rarely observed, it is possible that newly transcribed pre-mRNAs in-
teract on a short timescale with the mobile pool of nucleoplasmic
hnRNPs [59]. Additionally, many of hnRNPs A/B foci appeared to be
within a micron of a transcription factory and therefore could also be
available for interaction with pre-mRNAs shortly after their transcrip-
tion (Fig. 7). The importance of interactions between RNA and the
hnRNPs is reinforced by the observation that the focal distribution of
the hnRNPs A/B was abolished following inhibition of transcription
(Fig. 6), suggesting that the hnRNPs A/B interact with transcripts some
time after their synthesis.
The hnRNPs A/B recognise speciﬁc motifs in various mRNAs
[19,37,60,61], while different sequences in transcripts bind different
sets of hnRNPs [62]. Furthermore, A1 and A2/B1 have dissimilar
afﬁnities for newly spliced AdML and β-globin transcripts [63]. In
addition, hnRNPs A/B act as splicing silencers [15–19], which implies
that they would only be found on mRNAs undergoing exonic skipping.
Given that the hnRNPs A/B interact withmRNAs in a sequence-speciﬁc
manner, studies that look at pools of RNPs are unlikely to be able to
elucidate the true nature of these interactions.
The partial colocalisation of A2/B1 with splicing factors U2AF65,
snRNA and Sm proteins (Fig. 4) provides further support for its role
in splicing. This colocalisation was most prominent in the perinu-
cleolar region. There is now mounting evidence that the nucleolus
may be involved in the assembly of small nuclear RNPs (snRNPs),
which are precursors of spliceosomes [64]. Proteomic analyses of
nucleoli have also consistently identiﬁed a high proportion of pro-
teins (about 20%) that are involved in mRNA metabolism [21]. In
combination with our ﬁndings, this suggests that elevated levels ofmRNA processing, including the early stages of splicing, may take
place in the perinucleolar region.
snRNPs are assembled in the cytoplasm and imported back into the
nucleuswhere they undergomaturation in Cajal bodies. They then can
be stored in splicing factor compartments before incorporation into
spliceosomes to catalyze splicing [33,34]. Interestingly, A2/B1 does not
colocalise with SC-35, a marker for splicing factor compartments, or
with Cajal bodies (and closely related structures, GEMs), as marked by
concentrations of snRNAs, coilin or SMN (Fig. 4). This further suggests
that the association of A2/B1 with snRNP components occurs only in
the spliceosome. However, at the level of resolution employed in our
experiments, the possibility of additional non-spliceosomal functions
at these locations cannot be precluded.
During mitosis, many subnuclear compartments are relocalised as
the nucleus undergoes structural reorganisation. During prophase and
metaphase, splicing factors such as SC-35 and the snRNPs diffuse
throughout the cell body, before reassembling into Cajal bodies and
splicing factor compartments in late anaphase [65]. Similarly, we
found that the distribution of A2/B1 changed from a perinucleolar
enrichment during interphase to a more diffuse pattern throughout
mitosis, although there were some regional concentrations of A2/B1
staining (Fig. 8). Since the perinucleolar localisation of A2/B1 is
dependent on ongoing transcription (Fig. 6), these transitions may be
a consequence of the inhibition of transcription that occurs during
mitosis.
In summary, our results demonstrate that the hnRNPs A/B have
distinct subnuclear localisation patterns that are spatially and
temporally regulated. The distribution of A1 differs greatly from that
of A2/B1 and A3, and this localisation is maintained primarily by
interactions with RNA. The presence and absence of hnRNPs A/B from
particular subnuclear compartments may be related to their involve-
ment in speciﬁc stages of nuclear processes such as DNA replication
and splicing. Our ﬁndings suggest that while the hnRNPs A/B retain a
high degree of structural homology and have closely related roles in
processes such as RNA packaging, they have diverged to become
functionally distinct in other aspects. It will be of great interest to
further elucidate the differential contribution of these paralogues to
the many nuclear pathways in which they are involved.
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